Screener
Collegium Pharmaceutical, Inc. COLL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Collegium Pharmaceutical, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:34 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053851
FAQ
- What is Collegium Pharmaceutical, Inc.'s restricted cash?
- Collegium Pharmaceutical, Inc. (COLL) reported restricted cash of $19.85M in Q2 2026.
- How has Collegium Pharmaceutical, Inc.'s restricted cash changed year-over-year?
- Collegium Pharmaceutical, Inc.'s restricted cash decreased by 0.0% year-over-year, from $19.85M to $19.85M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s restricted cash has grown at a 50.8% compound annual growth rate (CAGR), from $2.55M to $19.85M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Collegium Pharmaceutical, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude